- Home
- TLSA vs VSTM Comparison
TLSA vs VSTM Comparison
Compare TLSA & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- VSTM
- Stock Information
- Founded
- TLSA 2013
- VSTM 2010
- Country
- TLSA United Kingdom
- VSTM United States
- Employees
- TLSA N/A
- VSTM N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- VSTM Health Care
- Exchange
- TLSA Nasdaq
- VSTM Nasdaq
- Market Cap
- TLSA 87.8M
- VSTM 132.0M
- IPO Year
- TLSA 2000
- VSTM 2012
- Fundamental
- Price
- TLSA $1.20
- VSTM $3.88
- Analyst Decision
- TLSA
- VSTM Strong Buy
- Analyst Count
- TLSA 0
- VSTM 8
- Target Price
- TLSA N/A
- VSTM $14.57
- AVG Volume (30 Days)
- TLSA 145.8K
- VSTM 1.1M
- Earning Date
- TLSA 05-10-2024
- VSTM 11-06-2024
- Dividend Yield
- TLSA N/A
- VSTM N/A
- EPS Growth
- TLSA N/A
- VSTM N/A
- EPS
- TLSA N/A
- VSTM N/A
- Revenue
- TLSA N/A
- VSTM $10,000,000.00
- Revenue This Year
- TLSA N/A
- VSTM N/A
- Revenue Next Year
- TLSA N/A
- VSTM $125.69
- P/E Ratio
- TLSA N/A
- VSTM N/A
- Revenue Growth
- TLSA N/A
- VSTM N/A
- 52 Week Low
- TLSA $0.41
- VSTM $2.10
- 52 Week High
- TLSA $1.74
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- TLSA 65.44
- VSTM 63.77
- Support Level
- TLSA $0.83
- VSTM $3.11
- Resistance Level
- TLSA $0.92
- VSTM $3.76
- Average True Range (ATR)
- TLSA 0.09
- VSTM 0.33
- MACD
- TLSA 0.03
- VSTM 0.04
- Stochastic Oscillator
- TLSA 84.52
- VSTM 94.26
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.